Tag
Tejash Maheshchandra Hathi
2 articles
Aptus Pharma Reports No IPO Fund Utilization Deviations
Aptus Pharma Limited filed a regulatory statement confirming no deviations in utilization of ₹13.02 crore IPO proceeds raised on September 29, 2025.
All funds were fully utilized as per original objec
Aptus Pharma Promoter Tejash Hathi Acquires 10,000 Shares
Promoter Tejash Maheshchandra Hathi discloses acquisition of 10,000 equity shares in Aptus Pharma Limited via off-market transaction on May 11, 2026.
The acquisition increases his total holding to 785